Dennis Bourdette is a Neurology physician affiliated with Oregon Health & Science University. OpenAlex indexes 369 publications with 16,598 citations (h-index 67); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Department Of Neurology, L226
Portland, OR 972393011
Telephone
503-494-7772Registry record last updated 8 Jul 2007.
Clinical trials
- A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis
Sponsor: VA Office of Research and Development
- Effects of Training on Central Auditory Function in Multiple Sclerosis
Sponsor: VA Office of Research and Development
- Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
Sponsor: US Department of Veterans Affairs
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.5%Potassium Channel Blocker28.8%Dalfampridine Er100%Part D<11 patientsBenzodiazepine11.7%Clonazepam100%Part D<11 patientsCancer & immunology
36%Interferon beta26.1%Avonex100%Part D<11 patientsOther immunostimulants9.9%Copaxone100%Part D<11 patientsMusculoskeletal
23.4%gamma-Aminobutyric Acid-ergic Agonist23.4%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1999–2016 per NIH RePORTER. The latest:
- A randomized trial of a formal group program for fatigue in multiple sclerosis
Portland Va Medical Center
FY2016I01RX000523 - A randomized trial of a formal group program for fatigue in multiple sclerosis
Portland Va Medical Center
FY2015I01RX000523 - A randomized trial of a formal group program for fatigue in multiple sclerosis
Portland Va Medical Center
FY2015I01RX000523
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”